Related Experiment Video

Updated: Aug 30, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Apoptosis: target for novel drugs

John J Alam1

  • 1Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, MA 02139, USA. John_alam@vrtx.com

Trends in Biotechnology
|October 24, 2003
PubMed

Insights

Targeting apoptosis pathways offers new drug development opportunities for cancer and acute diseases like stroke. Future research may extend these novel therapies to chronic disorders by understanding apoptosis mechanisms.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Apoptotic cell death pathways are crucial targets for novel drug discovery and development.
  • Existing therapies selectively induce apoptosis in cancer cells, with numerous pro-apoptotic drugs in development.
  • Anti-apoptotic drugs are advanced for acute conditions like stroke, myocardial infarction, and sepsis, where apoptosis is well-defined.

Purpose of the Study:

  • To explore the therapeutic potential of targeting apoptotic cell death pathways.
  • To review the current landscape of pro-apoptotic and anti-apoptotic drug development.
  • To identify future directions for drug discovery related to apoptosis in both acute and chronic diseases.

Main Methods:

  • Review of existing literature on apoptosis pathways and drug development.
  • Analysis of marketed and investigational drugs targeting apoptosis.
  • Examination of preclinical and clinical data for anti-apoptotic agents in acute diseases.

Main Results:

  • Targeted therapies inducing apoptosis in cancer are established, with ongoing development of pro-apoptotic drugs.
  • Anti-apoptotic drugs show promise for acute indications like stroke and sepsis, supported by animal model data.
  • Understanding apoptosis in chronic disorders presents future opportunities for novel therapeutic interventions.

Conclusions:

  • Targeting apoptosis is a validated strategy for cancer therapy and shows promise for acute diseases.
  • Further research into apoptotic pathways in chronic conditions could yield novel therapeutic approaches.
  • Apoptosis modulation represents a significant area for future pharmaceutical innovation.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...